Brief: AbbVie - Expands Board To Thirteen Directors On October 14, 2026 - SEC Filing
BRIEF-AbbVie - Expands Board To Thirteen Directors On October 14, 2026 - SEC Filing Oct 15 (Reuters) - AbbVie Inc. ABBV.N:
ABBVIE - EXPANDS BOARD TO THIRTEEN DIRECTORS ON OCTOBER 14, 2026 - SEC FILING
ABBVIE - APPOINTS JOHN M. CARETHERS AS CLASS II DIRECTOR - SEC FILING
Source text: [ID:n0001104659-26-116227]
Further company coverage: ABBV.N
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on AbbVie
See all newsBrief: Abbvie Reaches Agreement With The Pan-Canadian Pharmaceutical Alliance (Pcpa) For Elahere® In Platinum-Resistant Ovarian Cancer
Eli Lilly hits record high as healthcare stocks rally
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Abbvie Says Risankizumab In Ulcerative Colitis Shows Clinical Remission Rates Of 54.0%-73.1% At Week 96